ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,598, issued on April 21, was assigned to Bactoclear Holdings PTE Ltd. (Singapore).
"Chimeric klebicins" was invented by Anisha Ambady (Bangalore, India), Chemira Biddappa Appaiah (Bangalore, India), Vivek Daniel Paul (Bangalore, India), R. Sanjeev Saravanan (Bangalore, India) and Keerthana Anbalagan (Tamil Nadu, India).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides chimeric klebicins by combining translocation, receptor-binding, and bactericidal domains originated from different klebicins to achieve improved target cell range and bactericidal activity. Also provided are related compositions, kits, and methods of use of...